0.1700
0.0000
(0.00%)
At close: 3:30:05 PM EDT
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 3 |
| Avg. Estimate | -0.02 | -0.02 | -0.06 | -0.36 |
| Low Estimate | -0.02 | -0.02 | -0.06 | -0.96 |
| High Estimate | -0.02 | -0.02 | -0.06 | -0.04 |
| Year Ago EPS | -0.03 | -0.02 | -0.1 | -0.06 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | 10M | 200.33k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 30M | 601k |
| Year Ago Sales | -- | -- | -- | 10M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -98.00% |
Earnings History
| Currency in CAD | 4/30/2024 | 7/31/2024 | 10/31/2024 | 1/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.02 | -0.03 | -0.03 | -- |
| EPS Actual | -0.03 | -0.02 | -0.02 | -0.02 |
| Difference | -0.01 | 0.01 | 0.01 | -- |
| Surprise % | -50.00% | 33.33% | 40.60% | -- |
EPS Trend
| Currency in CAD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.02 | -0.02 | -0.06 | -0.36 |
| 7 Days Ago | 0 | 0 | -0.04 | -0.37 |
| 30 Days Ago | 0 | 0 | -0.04 | -0.36 |
| 60 Days Ago | 0 | 0 | -0.04 | -0.07 |
| 90 Days Ago | 0 | 0 | -0.04 | -0.07 |
EPS Revisions
| Currency in CAD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SVA.TO | 33.33% | 0.00% | 40.00% | -500.00% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Initiated | Raymond James: Market Perform | 4/4/2024 |
Related Tickers
SVA Sinovac Biotech Ltd.
6.47
0.00%
BETR.CN BetterLife Pharma Inc.
0.0850
0.00%
NK9.F Neuren Pharmaceuticals Limited
4.5400
-7.35%
RKV.V Rakovina Therapeutics Inc.
0.0550
-8.33%
WF6.MU MindBio Therapeutics Corp
0.0084
0.00%
CHGX.CN ChitogenX Inc.
0.0100
+100.00%
ANL Adlai Nortye Ltd.
1.9400
+7.18%
VCNX Vaccinex, Inc.
0.4800
+32.49%
QPT.V Quest PharmaTech Inc.
0.0550
0.00%
ONCY Oncolytics Biotech Inc.
0.6229
+26.43%